Infection Surveillance Solution Market - Global Forecast 2025-2032

Senior healthcare leaders recognize that infection surveillance is now critical to operational resilience and organizational compliance. As risks multiply and technology evolves, a strategic approach to infection surveillance solutions helps protect patient safety and sustain efficient healthcare delivery in a rapidly shifting environment.

Market Snapshot: Infection Surveillance Solution Market Overview

The global Infection Surveillance Solution Market continues to accelerate, forecast to grow from USD 867.99 million in 2024 to USD 985.81 million in 2025, at a robust CAGR of 13.80%. Projections suggest a sustained advancement, reaching USD 2.44 billion by 2032. This rapid development is underpinned by increasing digital monitoring, the rising complexity of healthcare-associated infection control, and a stronger need for scalable, data-driven platforms. Healthcare organizations are prioritizing adaptive technologies that enable responsive management of infection risks across all operational settings. As compliance standards evolve, investment in resilient surveillance supports quality care and optimized workflows.

Scope & Segmentation in the Infection Surveillance Solution Market

This market research report offers actionable insights tailored for executive teams guiding procurement, compliance, and strategic direction in infection surveillance. The segmentation analysis enables a comprehensive understanding of solution adoption and regional trends.

• Component: Consulting, implementation, integration, maintenance, upgrade strategies, user training, and advanced software. Each element supports seamless alert management, actionable analytics, and clear reporting throughout surveillance processes.
• Deployment Mode: Cloud-based models—public, private, or hybrid—and on-premises deployments address varied security, scalability, and IT requirements for global healthcare systems.
• Technology: Artificial intelligence, supervised and unsupervised machine learning, IoT-based monitoring, and rule-based engines support regulatory compliance and drive clinical workflow efficiencies.
• Application: Infection control initiatives, healthcare-associated infection surveillance (covering bloodborne and surgical types), outbreak response, contact tracing, genomic pathogen analysis, and syndromic monitoring all play key roles in early detection and intervention.
• End User: Hospitals, diagnostic laboratories, public health agencies, and research institutions deploy solutions tailored to their workflows and specialized reporting requirements.
• Regions: Market dynamics are analyzed across the Americas, Europe, Middle East and Africa, and Asia-Pacific, with a focus on unique regulatory, reimbursement, and competitive factors influencing regional adoption and growth strategies.

Featured Companies

• Becton, Dickinson and Company
• Thermo Fisher Scientific Inc.
• F. Hoffmann-La Roche Ltd
• bioMérieux SA
• Abbott Laboratories
• Siemens Healthineers AG
• Sysmex Corporation
• Bio-Rad Laboratories, Inc.
• QIAGEN N.V.
• Agilent Technologies, Inc.

Key Takeaways for Senior Decision-Makers

• Hybrid cloud and analytics-driven platforms promote timely, organization-wide coordination for infection risk management and operational response.
• Artificial intelligence and machine learning empower predictive surveillance, refining resource planning and providing the foundation for responsive, scalable infection control.
• Service-focused delivery models offer sustained strategic support throughout deployment, helping organizations remain agile with regulatory alignment and ongoing optimization.
• Local and international compliance is best achieved by integrating solutions compatible with both mobile-ready approaches and existing infrastructure.
• Choosing vendors with modular, adaptable portfolios allows organizations to pivot smoothly in response to evolving priorities and clinical demands.

Tariff Impact and Procurement Strategies

The planned implementation of 2025 U.S. tariffs on imported medical software and equipment is reshaping procurement within the Infection Surveillance Solution Market. Healthcare providers are mitigating anticipated ownership cost increases by prioritizing regional suppliers, exploring nearshoring opportunities, and structuring risk-sharing contracts with vendors. These strategies aim to strengthen supply chain resilience and maintain transparent, uninterrupted operations amid dynamic trade changes.

Methodology & Data Sources

The research incorporates structured interviews with healthcare epidemiologists, laboratory directors, and technology vendors. Findings are verified through compliance audits, literature analysis, and pilot program assessments, ensuring reliable and actionable data for executive leadership.

Why This Report Matters

• Guides executive teams to match infection surveillance investments with complex, changing regulations, minimizing operational and compliance burdens during procurement and digital transformation.
• Supports strategic decision-making for technology and vendor selection in light of evolving trade territories and regulatory frameworks.
• Fosters data-driven collaboration and benchmarking by providing timely, market-relevant intelligence and practical best practices for infection monitoring and control.

Conclusion

Access to up-to-date, in-depth market intelligence positions healthcare leaders to enhance infection surveillance resilience while navigating shifting regulations and technological advancements.

Additional Product Information:

• Purchase of this report includes 1 year online access with quarterly updates.
• This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.